Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01)

The summary for the Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01) Federal Grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the government agency that is offering this grant.
Federal Grant Title: Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01)
Federal Agency Name: Food and Drug Administration
Grant Categories: Agriculture Business and Commerce Community Development Education Employment Labor and Training Environment Food and Nutrition Health Information and Statistics Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-FD-11-024
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.103
CFDA Descriptions: Food and Drug Administration_Research
Current Application Deadline: Jul 18, 2011
Original Application Deadline: Jul 18, 2011
Posted Date: Jun 17, 2011
Creation Date: Jun 22, 2011
Archive Date: Jul 19, 2011
Total Program Funding: $250,000
Maximum Federal Grant Award: $50,000
Minimum Federal Grant Award:
Expected Number of Awards: 5
Cost Sharing or Matching: No
Grant Description
As part of FDA's Safe Use Initiative: Collaborating to Reduce Preventable Harm, FDA will identify drug/drug classes or therapeutic areas associated with preventable harm. The mission of the Safe use Initiative is to seek solutions to preventable harm associated with suboptimal use of regulated prescription and over the counter medications. The approach is to involve cross sector collaborations with other parts of healthcare committed to medication safety. This Funding Opportunity Announcement (FOA), issued by FDA, will provide resources for research to characterize preventable harm associated with specific FDA regulated drugs, identify sources (root causes) of the preventable harm and for the development and implementation of interventions to reduce the preventable harm.
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses
Link to Full Grant Announcement
Grant Announcement Contact
Stephanie Bogan Grants Management Specialist []
Similar Government Grants
Convener of Discussions on Medical Policy Issues Impacting Drug Development
Development of Clinically Relevant in Vitro Performance Test for Generic OIDPs: Physiologi...
Evaluation of in vitro release methods for liposomal drug products
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products
Pharmacometric Modeling and Simulation for Generic Drugs Evaluation
Support for Small Scientific Conference Grant Program
Cooperative Agreement to Support the World Health Organization (WHO) International Program...
Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the Food and Drug Administration
Cooperative Agreement to Support the Food and Agriculture Organization (U01)
Predictive Methods for Characterizing Product Performance in Pediatric Patients, Case Stud...
Cooperative Agreement to Support the World Trade Organization s (WTO) Standards and Trade ...
Cooperative Agreement to Support the North Carolina State University, Prestage Department ...
Development, Implementation, and Management of a Funding System to Advance Conformance wit... is not endorsed by, or affiliated with, any government agency. Copyright ©2014